Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation (Q36135849)

12 August 2017

Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation (English)

1 reference

12 August 2017

1 reference

I. G. Brown

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232724

3 September 2023

C. S. Chan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232724

3 September 2023

C. A. Kelly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232724

3 September 2023

A. G. Dent

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232724

3 September 2023

P. V. Zimmerman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232724

3 September 2023

language of work or name

English

0 references

publication date

1 April 1984

1 reference

PMC publication ID

459782

full work available at URL

12 August 2017

https://europepmc.org/articles/PMC459782

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232724

https://europepmc.org/articles/PMC459782?pdf=render

3 September 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6232724

https://syndication.highwire.org/content/doi/10.1136/thx.39.4.272

3 September 2023

1 reference

https://api.crossref.org/works/10.1136/THX.39.4.272

3 September 2023

1 reference

12 August 2017

39

1 reference

12 August 2017

4

1 reference

12 August 2017

272-276

1 reference

Ipratropium bromide in acute asthma.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Adverse reaction to ipratropium bromide.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Combined Cholinergic Antagonist and β2-Adrenoceptor Agonist Bronchodilator Therapy by Inhalation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Bronchodilatation and the site of airway resistance in severe chronic bronchitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Bronchodilator Action of the Anticholinergic Drug, Ipratropium Bromide (Sch 1000), as an Aerosol in Chronic Bronchitis and Asthma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

A comparison of the bronchodilator activity of Sch 1000 and salbutamol

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Inhaled atropine sulfate: dose-response characteristics in adult patients with chronic airflow obstruction.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459782

Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma

2 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6232724

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/THX.39.4.272

1 reference

12 August 2017

1 reference

PMC publication ID

459782

12 August 2017

1 reference

PMC publication ID

459782